300 related articles for article (PubMed ID: 38324529)
1. How important is EMT for cancer metastasis?
Celià-Terrassa T; Kang Y
PLoS Biol; 2024 Feb; 22(2):e3002487. PubMed ID: 38324529
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
3. [Epithelial-mesenchymal transition in health and disease].
Puchinskaya MV
Arkh Patol; 2015; 77(1):75-83. PubMed ID: 25868373
[TBL] [Abstract][Full Text] [Related]
4. EMT, MET, Plasticity, and Tumor Metastasis.
Bakir B; Chiarella AM; Pitarresi JR; Rustgi AK
Trends Cell Biol; 2020 Oct; 30(10):764-776. PubMed ID: 32800658
[TBL] [Abstract][Full Text] [Related]
5. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
6. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?
Diepenbruck M; Christofori G
Curr Opin Cell Biol; 2016 Dec; 43():7-13. PubMed ID: 27371787
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT).
Ding XM
Chin J Cancer; 2014 Mar; 33(3):140-7. PubMed ID: 24016392
[TBL] [Abstract][Full Text] [Related]
9. The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.
Meng F; Wu G
Cancer Metastasis Rev; 2012 Dec; 31(3-4):455-67. PubMed ID: 22733307
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Mesenchymal Transition in Tumor Metastasis.
Mittal V
Annu Rev Pathol; 2018 Jan; 13():395-412. PubMed ID: 29414248
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
12. Context-dependent EMT programs in cancer metastasis.
Aiello NM; Kang Y
J Exp Med; 2019 May; 216(5):1016-1026. PubMed ID: 30975895
[TBL] [Abstract][Full Text] [Related]
13. Epithelial to mesenchymal transition during mammalian neural crest cell delamination.
Zhao R; Trainor PA
Semin Cell Dev Biol; 2023 Mar; 138():54-67. PubMed ID: 35277330
[TBL] [Abstract][Full Text] [Related]
14. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
15. Cellular dynamics of EMT: lessons from live in vivo imaging of embryonic development.
Amack JD
Cell Commun Signal; 2021 Jul; 19(1):79. PubMed ID: 34294089
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis.
Huang Y; Hong W; Wei X
J Hematol Oncol; 2022 Sep; 15(1):129. PubMed ID: 36076302
[TBL] [Abstract][Full Text] [Related]
17. The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition.
Tripathi S; Levine H; Jolly MK
Annu Rev Biophys; 2020 May; 49():1-18. PubMed ID: 31913665
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression.
Bullock MD; Sayan AE; Packham GK; Mirnezami AH
Biol Cell; 2012 Jan; 104(1):3-12. PubMed ID: 22188537
[TBL] [Abstract][Full Text] [Related]
19. EMT: 2016.
Nieto MA; Huang RY; Jackson RA; Thiery JP
Cell; 2016 Jun; 166(1):21-45. PubMed ID: 27368099
[TBL] [Abstract][Full Text] [Related]
20. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
